Products
IN-006 | Inhalon Biopharma
Product description
IN-006 is an inhaled antibody treatment designed to trap pathogens in the lung mucus, blocking their spread and facilitating their rapid elimination. It is currently in Phase 1b clinical trials for the treatment of COVID-19.